The Pros and Cons of Diagnosing Diabetes With A1C

International Expert Committee, 2009, International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care, 32, 1327, 10.2337/dc09-9033

1997, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183

Engelgau, 1997, Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes: diagnostic criteria and performance revisited, Diabetes Care, 20, 785, 10.2337/diacare.20.5.785

McCance, 1994, Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes, BMJ, 308, 1323, 10.1136/bmj.308.6940.1323

Colagiuri, 2003, DETECT-2: early detection of type 2 diabetes and IGT, Diabetes Voice, 48, 11

The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group, 2001, Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-h diagnostic criteria, Arch Intern Med, 161, 397, 10.1001/archinte.161.3.397

Khaw, 2004, Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk, Ann Intern Med, 141, 413, 10.7326/0003-4819-141-6-200409210-00006

Mikesh, 2008, Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis, Clin Chem, 54, 930, 10.1373/clinchem.2007.102160

Bruns, 2009, Stabilization of glucose in blood samples: why it matters, Clin Chem, 55, 850, 10.1373/clinchem.2009.126037

Consensus Committee, 2007, Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation, Diabetes Care, 30, 2399, 10.2337/dc07-9925

Miller, 2008, State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry, Arch Pathol Lab Med, 132, 838, 10.5858/2008-132-838-SOTAIT

Selvin, 2007, Short-term variability in measures of glycemia and implications for the classification of diabetes, Arch Intern Med, 167, 1545, 10.1001/archinte.167.14.1545

Rohlfing, 2002, Biological variation of glycohemoglobin, Clin Chem, 48, 1116, 10.1093/clinchem/48.7.1116

McCarter, 2004, Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes, Diabetes Care, 27, 1259, 10.2337/diacare.27.6.1259

Selvin, 2010, Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults, N Engl J Med, 362, 800, 10.1056/NEJMoa0908359

Carson, 2010, Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults, Diabetes Care, 33, 95, 10.2337/dc09-1227

Abdul-Ghani, 2010, The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes, Diabetes Metab Res Rev, 26, 280, 10.1002/dmrr.1084

Zhou, 2010, Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China, Diabetes Care, 33, 545, 10.2337/dc09-1410

Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801

Cowie, 2010, Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006, Diabetes Care, 33, 562, 10.2337/dc09-1524

Mohan, 2010, A1C cut points to define various glucose intolerance groups in Asian Indians, Diabetes Care, 33, 515, 10.2337/dc09-1694

Herman, 2007, Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program, Diabetes Care, 30, 2453, 10.2337/dc06-2003

Christensen, 2010, Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups, Diabetes Care, 33, 580, 10.2337/dc09-1843

Barr, 2009, Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study, Diabetologia, 52, 415, 10.1007/s00125-008-1246-y

de Vegt, 1999, Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study, Diabetologia, 42, 926, 10.1007/s001250051249

Nakagami, 2006, Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study, Eur J Cardiovasc Prev Rehabil, 13, 555, 10.1097/01.hjr.0000183916.28354.69

Qiao, 2004, Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c, J Clin Epidemiol, 57, 590, 10.1016/j.jclinepi.2003.10.007

Hanefeld, 1996, Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up, Diabetologia, 39, 1577, 10.1007/s001250050617

Eriksson, 1998, No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise, Diabetologia, 41, 1010, 10.1007/s001250051024

Uusitupa, 2009, Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study: secondary analysis of the randomized trial, PLoS ONE, 4, e5656, 10.1371/journal.pone.0005656

Haliassos, 2006, Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants, Clin Chem Lab Med, 44, 223, 10.1515/CCLM.2006.041

Anand, 2003, Diagnostic strategies to detect glucose intolerance in a multiethnic population, Diabetes Care, 26, 290, 10.2337/diacare.26.2.290

Pajunen, 2011, HbA1c in diagnosing type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study, Diabet Med, 28, 36, 10.1111/j.1464-5491.2010.03183.x